Skip to main content
PMC home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1975;6:38–44. doi: 10.1136/jcp.s1-6.1.38

Activation of complement in relation to disease.

J M Versey, L Slater, J R Hobbs
PMCID: PMC1436070  PMID: 802871

Full text

PDF
41

Images in this article

40Fig 4
on p.40

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson N., Alper C. A., Lachmann P. J., Rosen F. S., Jandl J. H. Deficiency of C3 inactivator in man. J Immunol. 1971 Jul;107(1):19–27. [PubMed] [Google Scholar]
  2. Arroyave C. M., Vallota E. H., Müller-Eberhard H. J. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF). J Immunol. 1974 Sep;113(3):764–768. [PubMed] [Google Scholar]
  3. Boenisch T., Alper C. A. Isolation and properties of a glycine-rich beta-glycoprotein of human serum. Biochim Biophys Acta. 1970 Dec 22;221(3):529–535. doi: 10.1016/0005-2795(70)90224-2. [DOI] [PubMed] [Google Scholar]
  4. Cameron J. S., Vick R. M., Ogg C. S., Seymour W. M., Chantler C., Turner D. R. Plasma C3 and C4 concentrations in management of glomerulonephritis. Br Med J. 1973 Sep 29;3(5882):668–672. doi: 10.1136/bmj.3.5882.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gewurz H., Pickering R. J., Mergenhagen S. E., Good R. A. The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol. 1968;34(6):556–570. doi: 10.1159/000230149. [DOI] [PubMed] [Google Scholar]
  6. Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med. 1968 Nov 1;128(5):1049–1057. doi: 10.1084/jem.128.5.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grieco M. H., Capra J. D., Paderon H. Reduced serum beta 1c/1a globulin levels in extrarenal disease. Am J Med. 1971 Sep;51(3):340–345. doi: 10.1016/0002-9343(71)90269-5. [DOI] [PubMed] [Google Scholar]
  8. Hanauer L. B., Christian C. L. Clinical studies of hemolytic complement and the 11S component. Am J Med. 1967 Jun;42(6):882–890. doi: 10.1016/0002-9343(67)90069-1. [DOI] [PubMed] [Google Scholar]
  9. Hobbs J. R. Immunoglobulins in clinical chemistry. Adv Clin Chem. 1971;14:219–317. doi: 10.1016/s0065-2423(08)60147-x. [DOI] [PubMed] [Google Scholar]
  10. Kohler P. F., Müller-Eberhard H. J. Complement-immunoglobulin relation: deficiency of C'1q associated with impaired immunoglobulin G synthesis. Science. 1969 Jan 31;163(3866):474–475. doi: 10.1126/science.163.3866.474. [DOI] [PubMed] [Google Scholar]
  11. Kohler P. F., Ten Bensel R. Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. Clin Exp Immunol. 1969 Feb;4(2):191–202. [PMC free article] [PubMed] [Google Scholar]
  12. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  13. LEPOW I. H., RATNOFF O. D., LEVY L. R. Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med. 1958 Mar 1;107(3):451–474. doi: 10.1084/jem.107.3.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  16. MACFARLANE R. G. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. Nature. 1964 May 2;202:498–499. doi: 10.1038/202498a0. [DOI] [PubMed] [Google Scholar]
  17. Miller M. E., Nilsson U. R. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med. 1970 Feb 12;282(7):354–358. doi: 10.1056/NEJM197002122820702. [DOI] [PubMed] [Google Scholar]
  18. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  19. Müller-Eberhard H. J., Fjellström K. E. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J Immunol. 1971 Dec;107(6):1666–1672. [PubMed] [Google Scholar]
  20. Nelson R. A., Jr A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity. Surv Ophthalmol. 1966 Aug;11(4):498–505. [PubMed] [Google Scholar]
  21. Nelson R. A., Jr, Biro C. E. Complement components of a haemolytically deficient strain of rabbits. Immunology. 1968 Apr;14(4):527–540. [PMC free article] [PubMed] [Google Scholar]
  22. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  23. RESSLER N. Two-dimensional electrophoresis of protein antigens with an antibody containing buffer. Clin Chim Acta. 1960 Nov;5:795–800. doi: 10.1016/0009-8981(60)90111-x. [DOI] [PubMed] [Google Scholar]
  24. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  25. Sjöholm A. G., Laurell A. B. Conversion of the fourth complement component studied by crossed immunoelectrophoresis. Clin Exp Immunol. 1973 Aug;14(4):515–529. [PMC free article] [PubMed] [Google Scholar]
  26. Spitzer R. E., Vallota E. H., Forristal J., Sudora E., Stitzel A., Davis N. C., West C. D. Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969 Apr 25;164(3878):436–437. doi: 10.1126/science.164.3878.436. [DOI] [PubMed] [Google Scholar]
  27. Tamura N., Nelson R. A., Jr Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum. J Immunol. 1967 Sep;99(3):582–589. [PubMed] [Google Scholar]
  28. VAUGHAN J. H., BAYLES T. B., FAVOUR C. B. Serum complement in rheumatoid arthritis. Am J Med Sci. 1951 Aug;222(2):186–192. [PubMed] [Google Scholar]
  29. Versey J. M., Hobbs J. R., Holt P. J. Complement metabolism in rheumatoid arthritis. I. Longitudinal studies. Ann Rheum Dis. 1973 Nov;32(6):557–564. doi: 10.1136/ard.32.6.557. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES